US Stock Market Move | Weight loss drug newcomer Kailera Therapeutics (KLRA.US) debuted on the US stock market with an opening surge of over 50%.

On Friday, the new weight loss drug company Kailera Therapeutics (KLRA.US) landed on the US stock market, surging over 50% at the opening to $24.1, with an IPO price of $16. The company set a record for the largest IPO in the US biotech industry in 2021. Founded in 2024, Kailera is a late-stage biotech company developing four GLP-1-based weight loss drugs, including a once-weekly injection and a once-daily oral pill, both of which are currently in late-stage clinical trials.